Document:

EX-10.2

 Exhibit 10.2 
  

			
	

		EXECUTIVE EMPLOYMENT CONTRACT

 THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of May 1,
2015 (the “Effective Date”) by and between Potbelly Corporation, a Delaware corporation (hereinafter referred to as “Company”), and John Morlock, an individual (hereinafter referred to as “Executive”). 

Statement of Purpose 

WHEREAS, Executive is currently employed by Company and is party to an Executive Employment Agreement dated as of July 25, 2013 (the
“Prior Agreement”); and 
 WHEREAS, the Company desires to change Executive’s position to Senior Vice President, Operations
Growth and Executive desires to accept such employment on the terms and conditions set forth below; and 
 WHEREAS, Company and Executive
desire to definitively set forth their agreement with respect to Executive’s employment in this Agreement which supersedes and replaces the Prior Agreement; and 

WHEREAS, Potbelly Illinois, Inc. and Potbelly Sandwich Works, LLC are direct or indirect subsidiaries of the Company; 

NOW, THEREFORE, in consideration of the Statement of Purpose, the terms and provisions of this Contract and other good and valuable
consideration, the parties hereto mutually consent, covenant, represent, warrant, and agree as follows: 
 1. Term, Employment and
Duties. 
 (a) Term. The “Term” of this Agreement shall commence on the Effective Date and shall terminate on the date
the Executive’s employment with Company and its affiliates terminates for any reason (“Termination Date”). Executive shall at all times be an at-will employee and nothing in this Agreement shall constitute or be evidence of any
agreement or understanding, express or implied, that Executive has a right to continue to be employed by Company for any period of time or any specific rate of compensation. 

(b) Title and Duties. Effective as of the Effective Date, Company hereby agrees to continue to employ Executive, and Executive agrees
to continue in the employ of Company, as Company’s Senior Vice President, Operations Growth. Executive shall also have the commensurate titles and positions with such subsidiaries of affiliates of Company as determined by Company and shall
serve in such positions without additional compensation. Executive shall have the duties, responsibilities and authority customary for his positions, and shall perform such other duties consistent with such positions as may be assigned to Executive,
from time to time, by Company. 
 (c) Performance of Duties. Executive shall devote at least 30 hours per week exclusively to the
business, affairs, and interests of Company and its affiliates, and shall use Executive’s best efforts and abilities to promote the interests of Company and its affiliates and to perform the services contemplated by this Agreement and agrees
that he will perform his duties faithfully and efficiently subject to the directions of the CEO. Without the prior approval of the Company’s CEO or the executive to whom he reports, Executive shall not, during the Term, directly or indirectly,
render any other employment or consulting activities or services, including as a director, to any other person, firm, corporation, or other entity; provided, however, that, to the extent that the following activities do not conflict with or detract
from the performance by Executive of Executive’s duties, Executive may act as a director of, and may also engage in activities involving, charitable, educational, religious, and similar types of organizations, and similar types of activities.

 (d) Confidentiality, Non-Competition, Non-Interference and Intellectual Property. Executive hereby acknowledges and confirms that
the Executive Confidentiality and Non-Compete Agreement signed by Executive and effective as of the Effective Date is hereby incorporated into and forms a part of this Agreement. 

  
 1 

 EXECUTIVE EMPLOYMENT AGREEMENT

  

 2. Termination of Employment. 

(a) Termination Date. Executive’s Termination Date shall occur upon termination by Company for any reason or no reason or by
Executive for any reason or no reason, including any of the following: (i) Executive’s death; (ii) Executive being disabled by reason of physical and mental infirmity or both, thereby rendering Executive unable to satisfactorily
perform Executive’s duties under this Agreement (a “Disability”), said Disability to be determined in good faith by the CEO in consultation with no fewer than two (2) accredited physicians selected by the CEO and reasonably
approved by Executive in the event that Disability is disputed; (iii) termination of Executive’s employment by Company with or without Cause (as defined below) or (iv) Executive’s resignation. Executive’s Termination Date
shall be considered to be on account of a “Qualifying Termination” if the Termination Date occurs due to termination by Company without Cause. 

(b) Cause. The term “Cause” as used in this Agreement shall mean an act, action, or series of acts or actions, or omission
or series of omissions, by Executive which constitute or result in: (i) intentional misrepresentation of material information by Executive in Executive’s relations with Company; (ii) Executive’s indictment (or its equivalent) for
the commission of a crime by Executive that constitutes a felony; (iii) commission of an act involving moral turpitude; (iv) the material breach or material default by Executive of any of Executive’s written agreements with Company or
obligations under any material provision of this Agreement or any written policy of Company (that remains unremedied within thirty (30) days after notice to Executive); (v) the commission of fraud or embezzlement on the part of Executive;
(vi) failure to comply with any lawful written direction of Company’s Board of Directors (the “Board”) (that, if capable of cure without damage to Company, remains unremedied within thirty (30) days after notice to
Executive); or (vii) willful action taken for the purpose of harming Company or any of its affiliates. For purposes of clause (vii) of this Paragraph 2(b), no act or failure to act, on the part of Executive, shall be considered
“willful” unless it is done or omitted to be done, by Executive in bad faith and without reasonable belief that Executive’s action or omission was in the best interest of Company. An act, or failure to act, based upon authority given
pursuant to a resolution duly adopted by the Board shall be conclusively presumed to be done, or omitted to be done, by Executive in good faith and in the best interest of Company. 

3. Compensation and Benefits During Employment. 

(a) Base Salary. Effective as of May 15, 2015 and continuing during the term of Executive’s employment hereunder, Company
shall pay to Executive a base salary at an annual rate of $160,000.00 (the “Base Salary”). The Base Salary may be increased from time to time at the recommendation of the CEO and approved by the Compensation Committee of the Board (the
“Compensation Committee”). 
 (b) Annual Bonus. Executive shall be eligible for a discretionary “Annual Bonus”
at the recommendation of the CEO and approved by the Compensation Committee. Executive’s bonus shall be paid in a single lump sum cash payment not later than June 15 following the conclusion of the calendar year in which such bonus is
earned, provided, however, that if the annual audit for such calendar year has not been issued by Company’s outside auditors by said June 15, then payment shall be made within thirty (30) days following the issuance of such audit, but
in no event shall payment be made later than the end of the calendar year following the calendar year in which such bonus is earned. 

(c) Time Off. During the Term, Executive shall be entitled to vacation consistent with Company practice and policy for executive-level
employees, but not less than fifteen (15) days per year. In addition, Executive shall be entitled to those paid holidays granted to Company employees while Executive is employed. 

(d) Executive Benefits/Perquisites. Executive shall be entitled to such other benefits, including health insurance, dental, 401(k),
and other benefits and perquisites in such form and in such manner and at such times as Company shall from time to time adopt and establish for its executive-level employees generally. Executive shall be subject to eligibility and other requirements
of applicable benefit plans. 
 (e) Expenses. Company shall pay or reimburse Executive for all reasonable business expenses actually
incurred or paid by Executive during the Term in the performance of Executive’s duties and responsibilities under this Agreement, subject to and in accordance with applicable expense reimbursement policies as in effect from time to time. 

  
 2 

 EXECUTIVE EMPLOYMENT AGREEMENT

  

 (f) Equity Awards. If Executive resigns his employment on account of retirement
(which, solely for purposes of this Paragraph 3(f), shall mean a resignation by Executive with or without good reason after Executive has attained at least age 57 and completed at least 10 years of service with the Company and if such termination is
not for any other reason), all vested stock options that were vested and outstanding as of July 25, 2013 and that continue to be outstanding on the Termination Date shall remain exercisable in accordance with the terms of the stock option
agreement evidencing such stock option for five (5) years after the Termination Date (or, if less, the expiration date of such stock option). Notwithstanding the preceding sentence, if, after the Termination Date, Executive becomes employed on
a full-time basis or provides consulting services on a full-time basis for another employer or entity (as determined in the reasonable judgment of the Board) (the “Reemployment Date”), then the options shall remain exercisable in
accordance with the terms of the stock option agreement evidencing such stock option until the earlier of (i) ninety (90) days following the Reemployment Date or (i) the expiration date of the stock option term. All other stock
options outstanding on Executive’s Termination Date shall remain exercisable for ninety (90) days following the Termination Date or for such longer or shorter period specified under the stock option agreement evidencing such stock option
but in no event after the expiration of the stock option term. Executive shall provide written notice to the Company of any post-Termination Date employment that could reasonably be expected to constitute full-time employment for purposes of this
Paragraph 3(f). 
 4. Payments and Benefits on Termination of Employment. 

(a) Termination for any Reason. If Executive’s Termination Date occurs for any reason, Company shall pay or provide to Executive
(i) Executive’s Base Salary for the period ending on the Termination Date; (ii) Executive’s earned but unpaid Annual Bonus for any bonus year ending prior to the bonus year during which the Termination Date occurs;
(iii) reimbursement of Executive’s incurred but unreimbursed business expenses for periods prior to Executive’s Termination Date; and (iv) any other payments or benefits to be provided to Executive by Company pursuant to any
employee benefit plans or arrangements of Company or required by applicable law, to the extent such amounts are due from Company. Executive will be entitled to any other benefits in accordance with the terms of the applicable benefit plan or
program. Unless Executive resigns his employment on account of retirement as set forth in Paragraph 3(f) above, all stock options outstanding on Executive’s Termination Date shall remain exercisable for ninety (90) days following the
Termination Date or for such longer or shorter period specified under the stock option agreement evidencing such stock option but in no event after the expiration of the stock option term. 

(b) Qualifying Termination. If Executive’s Termination Date occurs prior to December 31, 2015 by reason of a Qualifying
Termination and if the Release Requirements (as defined Paragraph 4(d)) are satisfied as of the sixtieth (60th) day following the Termination Date (which sixtieth (60th) day shall be referred to as the “Payment Date”), then, in addition to the payments and benefits to which Executive is entitled under Paragraph 4(a), Executive will be entitled to the
following payments and benefits: 
 (i) Company shall pay Executive a cash severance payment in a gross amount equal to six
(6) months of Executive’s Base Salary (determined as of the Termination Date) (the “Severance Payment”). Any Severance Payment to which Executive is entitled under this Paragraph 4(b)(i) will commence on the first regular payroll
date after the Payment Date and shall continue to be paid in substantially equal payroll by payroll period installments for a period of six (6) months thereafter. 

(ii) If Executive is entitled to and elects continuation coverage under Company’s group health plans pursuant to
“COBRA” (“COBRA Coverage”), Company shall continue to pay on behalf of Executive and his eligible dependents the same level of employer contribution that is provided by Company for corresponding coverage for similarly-situated
active employees for the lesser of (1) six (6) months following Executive’s Termination Date or (2) the date on which COBRA Coverage terminates by its terms (the “Post-Termination Coverage Benefit”). Company shall have
no obligations under this Paragraph 4(b)(ii) if the Post-Termination Coverage Benefit would subject Company or any of its affiliates to tax penalties or materially increase the cost to Company and its affiliates of providing group

  
 3 

 EXECUTIVE EMPLOYMENT AGREEMENT

  

 
medical coverage to employees generally. For the period commencing on Executive’s Termination Date and ending on the Payment Date, the COBRA Coverage shall be provided at Executive’s
expense and, if the Release Requirements are satisfied on the Payment Date, Executive shall be entitled to a lump sum payment in an amount equal to the Post-Termination Coverage Benefit that would have been provided to Executive for the period
beginning on the Termination Date and ending on the Payment Date, which lump sum payment shall be made on the Payment Date or the next scheduled payroll date. 

(iii) Company shall pay Executive a cash payment equal to 5/12 of the amount of the Annual Bonus that Executive would have
received for the bonus year in which the Termination Date occurs had his Termination Date not occurred, based on actual Company performance, payable at the same time as the annual bonus is paid to similarly-situated active named executive officer
employees in accordance with the terms of the applicable bonus plan of Company. 
 If the Release Requirements are not satisfied on the Payment Date,
Executive shall not be entitled to any payments or benefits under this Paragraph 4(b). 
 (c) Company Property. Upon
Executive’s Termination Date, Executive will promptly return to Company all the documents and/or property of or relating to Company or any of its affiliates within Executive’s possession or control. 

(d) Release Requirements. For purposes of this Agreement, the “Release Requirements” shall be satisfied as of any
date if, as of such date, Executive (or, for purposes of Paragraph 4(e), the legal representative of Executive’s estate) has signed a form of general release and waiver satisfactory to Company and Executive if prior to death (the
“Release”) and the Release has become effective in accordance with applicable law (including that the Release has not revoked and the revocation period applicable under applicable law has expired). 

(e) Termination by Reason of Death or Disability. If Executive’s Termination Date occurs by reason of death or Disability
and the Release Requirements are satisfied (which, in the case of death shall be satisfied by the legal representative of Executive’s estate), then, in addition to the payments and benefits to which Executive is entitled under Paragraph 4(a),
Company shall pay to Executive or the legal representative of his estate, as applicable, a cash payment equal to the amount of the Annual Bonus that Executive would have received for the bonus year in which the Termination Date occurs had his
Termination Date not occurred, based on actual Company performance and pro-rated for the portion of the bonus year completed prior to the Termination Date, payable at the same time as the annual bonus is paid to similarly-situated active executive
employees in accordance with the terms of the applicable bonus plan of Company. 
 5. Mitigation and Set-Off. Executive shall not be
required to mitigate the amount of any payment provided for in this Agreement by seeking other employment or otherwise. Company shall not be entitled to set off against the amounts payable to Executive under this Agreement any amounts earned by
Executive in other employment after termination of his employment with Company or any amounts which might have been earned by Executive in other employment had he sought such other employment; provided, however that Company shall be entitled to set
off against the amounts payable to Executive under this Agreement any amounts owed to Company by Executive. 
 6. Reimbursements. To
the extent that any reimbursements under this Agreement are taxable to Executive, such reimbursements shall be paid to Executive only if (a) to the extent not specified herein, the expenses are incurred and reimbursable pursuant to a
reimbursement plan that provides an objectively determinable nondiscretionary definition of the expenses that are eligible for reimbursement and (b) the expenses are incurred during the Term. With respect to any expenses that are reimbursable
pursuant to the preceding sentence, the amount of the expenses that are eligible for reimbursement during one calendar year may not affect the amount of reimbursements to be provided in any subsequent calendar year, the reimbursement of an eligible
expense shall be made no later than the last day of the calendar year following the calendar year in which the expense was incurred, and the right to reimbursement of the expenses shall not be subject to liquidation or exchange for any other
benefit. 

  
 4 

 EXECUTIVE EMPLOYMENT AGREEMENT

  

 7. Notices. Notices and all other communications provided for in this Agreement shall
be in writing and shall be delivered personally or sent by registered or certified mail, return receipt requested, postage prepaid, or sent by facsimile or prepaid overnight courier to the parties at the addresses set forth below (or such other
addresses as shall be specified by the parties by like notice). Communications that are to be delivered by the U.S. mail or by overnight service are to be delivered to the addresses set forth below: 

to Company: 
 Potbelly Corporation

 222 Merchandise Mart Plaza Suite 2300 

Chicago, Illinois 60654 

Attention: General Counsel 
 or to
Executive, to Executive’s home address as reflected in Company’s records. 
 Each party, by notice furnished to the other party, may modify the
applicable delivery address, except that notice of change of address shall be effective only upon receipt. 
 8. Non-Waiver. No
waiver by either party or any breach by the other party of any provision hereof shall be deemed to be a waiver of any later or other breach thereof or as a waiver of any such or other provision of this Agreement. 

9. Governing Law and Choice of Forum. The construction, validity, and enforceability of this Agreement shall be governed by the laws of
the State of Illinois, as that law applies to contracts made, and to be wholly performed, in the State of Illinois. 
 10. Binding
Effect. This Agreement shall be binding upon and inure to the benefit of Company, Executive, and Executive’s personal representatives, beneficiaries, heirs, and successors. Company will require any successor (whether direct or indirect, by
purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that Company would be required to
perform it if no such succession has taken place. 
 11. Severability. If any provision of this Agreement or any part thereof be held
invalid or unenforceable, the same shall not affect or impair any other provision of this Agreement or any part thereof, and the invalidity or unenforceability of any provision of this Agreement shall not have any effect on or otherwise impair or
limit the other obligations of Company or Executive. 
 12. Counterparts. This Agreement may be executed in duplicate counterparts,
each of which shall be deemed an original hereof. 
 13. Disputes. Except as set forth in this Paragraph 13, any dispute, claim or
difference arising between Company and Executive (each a “Party,” and jointly, the “Parties”), including any dispute, claim or difference arising out of this Agreement, will be settled exclusively by binding arbitration in
accordance with the rules of the Judicial Arbitration and Mediation Services, Inc. (“JAMS”). The arbitration will be held Chicago, Illinois unless the Parties mutually agree otherwise. Nothing contained in this Paragraph 13 will be
construed to limit or preclude a Party from bringing any action in any court of competent jurisdiction for injunctive or other provisional relief to compel another party to comply with its obligations under this Agreement or any other agreement
between or among the Parties during the pendency of the arbitration proceedings. Each Party shall bear its own costs and fees of the arbitration, and the fees and expenses of the arbitrator will be borne equally by the Parties, provided, however, if
the arbitrator determines that any Party has acted in bad faith, the arbitrator shall have the discretion to require any one or more of the Parties to bear all or any portion of fees and expenses of the Parties and/or the fees and expenses of the
arbitrator; provided, further that, with respect to claims that, but for this mandatory arbitration clause, could be brought against Company under any applicable federal or state labor or employment law (“Employment Law”), the arbitrator
shall be granted and shall be required to exercise all discretion belonging to a court of competent jurisdiction under such Employment Law to decide the dispute, 

  
 5 

 EXECUTIVE EMPLOYMENT AGREEMENT

  

 
whether such discretion relates to the provision of discovery, the award of any remedies or penalties, or otherwise and provided further that Company may be required to pay filing or
administrative fees in the event that requiring Executive to pay such fees would render this Paragraph 13 unenforceable under applicable law. As to claims not relating to Employment Laws, the arbitrator shall have the authority to award any remedy
or relief that a Court of the State of Illinois could order or grant. The decision and award of the arbitrator shall be in writing and copies thereof shall be delivered to each Party. The decision and award of the arbitrator shall be binding on all
Parties. In rendering such decision and award, the arbitrator shall not add to, subtract from or otherwise modify the provisions of this Agreement. Either Party to the arbitration may seek to have the award of the arbitrator entered in any court
having jurisdiction thereof. All aspects of the arbitration shall be considered confidential and shall not be disseminated by any Party with the exception of the ability and opportunity to prosecute its claim or assert its defense to any such claim.
The arbitrator shall, upon request of either Party, issue all prescriptive orders as may be required to enforce and maintain this covenant of confidentiality during the course of the arbitration and after the conclusion of same so that the result
and underlying data, information, materials and other evidence are forever withheld from public dissemination with the exception of its subpoena by a court of competent jurisdiction in an unrelated proceeding brought by a third party. 

14. Assignment and Survival. This Agreement is personal to Executive and shall not be assignable by Executive. This Agreement may be
assigned by Company only to a successor-in interest to all or substantially all of the business operations of Company or any of its affiliates. The rights and obligations of the parties to this Agreement shall survive its termination or expiration
of this Agreement to the extent that any performance is required under this Agreement after the termination or expiration of the Agreement. 

15. No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rule of strict construction will be used against any person. 
 16. Indemnification. If Executive (or his
heirs, executors or administrators) is made a party or is threatened to be made a party to, or is involved in, any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of
the fact that Executive is or was a director or officer of Company or is or was serving at the request of Company as a director or officer of another corporation, partnership, joint venture, trust or other enterprise, Executive (and his heirs,
executors or administrators) shall be indemnified and held harmless by Company to the fullest extent permitted by Delaware Law. To the fullest extent authorized by Delaware Law, the right to indemnification conferred in this Paragraph 16 shall also
include the right to be paid by Company the expenses incurred in connection with any such proceeding in advance of its final disposition upon delivery to Company of an undertaking by or on behalf of Executive to repay such amount if it shall
ultimately be determined that Executive is not entitled to be indemnified. Company’s obligations under this Paragraph 16 shall survive the termination or expiration of this Agreement for any reason. 

17. Withholding. All payments and benefits under this Agreement are subject to withholding of all applicable taxes. 

18. Special Section 409A Rules. It is intended that this Agreement will comply with section 409A of the Internal Revenue Code of
1986, as amended (the “Code”), to the extent applicable, and this Agreement shall be interpreted and construed on a basis consistent with such intent. Notwithstanding any other provision of this Agreement to the contrary, if any payment or
benefit hereunder is subject to section 409A of the Code, and if such payment or benefit is to be paid or provided on account of Executive’s Termination Date (or other separation from service or termination of employment): 

(a) and if Executive is a specified employee (within the meaning of section 409A(a)(2)(B) of the Code) and if any such payment or benefit is
required to be made or provided prior to the earlier of (i) the first (1st) day of the seventh (7th) month following
Executive’s separation from service or (ii) the date of Executive’s death (the “Section 409A Payment Date”), such payment or benefit shall be delayed until the Section 409A Payment Date; and 

  
 6 

 EXECUTIVE EMPLOYMENT AGREEMENT

  

 (b) the determination as to whether Executive has had a termination of employment (or
separation from service) shall be made in accordance with the provisions of section 409A of the Code and the guidance issued thereunder without application of any alternative levels of reductions of bona fide services permitted thereunder. 

For purposes of section 409A of the Code, any installment payment or benefit under this Agreement shall be treated as a separate payment. If this Paragraph 18
applies to any payment or benefit hereunder, any such payments or benefits that would otherwise have been paid or provided to Executive between Executive’s Termination Date and the Section 409A Payment Date, shall be paid in a lump sum on
the Section 409A Payment Date. 
 19. Entire Agreement. This Agreement, together with Executive Confidentiality and Non-Compete
Agreement in effect on the Effective Date, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes and cancels all prior or contemporaneous oral or written agreements and understandings between
them with respect to the subject matter hereof, except as otherwise specifically stated in this Agreement, including the Prior Agreement; provided, however, that nothing in this Agreement shall supersede the provisions of the Stock Terms Agreement
which was included as Exhibit C to the Prior Agreement. This Agreement may not be changed or modified orally but only by an instrument in writing signed by the parties hereto, which instrument states that it is an amendment to this Agreement. 

[signature page follows] 

  
 7 

 EXECUTIVE EMPLOYMENT AGREEMENT

  

 IN WITNESS WHEREOF, intending to be legally bound, Company and Executive have executed this
agreement as of the date set forth below. 
  

							
	 Dated as of May 1, 2015
				POTBELLY CORPORATION
			
					 /s/ Aylwin Lewis

				
					By:		Aylwin Lewis
				
					Its:		President and Chief Executive Officer
			
					EXECUTIVE:
			
					 /s/ John Morlock

			
					John Morlock

  
 8EX-10.41

 Exhibit 10.41 
  

			
	Confidential	  	EXECUTION COPY

 AMENDMENT NO. 7 TO COLLABORATION 

AND OPTION AGREEMENT 
 This Amendment No. 7
to the Agreement (this “Amendment No. 7”) is entered into as of March 19, 2015 (the “Amendment Effective Date”) by and between Cytokinetics, Incorporated (“Cytokinetics” or
“CK”), a Delaware corporation, having its principal place of business at 280 East Grand Ave., South San Francisco, California 94080 and Amgen Inc., a Delaware corporation having its principal place of business at One Amgen Center
Drive, Thousand Oaks, California 91320 (“Amgen”). 
 WHEREAS, Cytokinetics and Amgen are parties to that certain
Collaboration and Option Agreement dated December 29, 2006, as amended (the “Agreement”); 
 WHEREAS, the Parties are
conducting a Research Program and wish to extend such program through December 31, 2015; 
 NOW, THEREFORE, in consideration of the
mutual promises and covenants set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, CK and Amgen, intending to be legally bound, agree to amend the Agreement as set forth below.

  

	1.	Definitions. Capitalized terms used herein and not otherwise defined have the meaning ascribed in the Collaboration Agreement. 

 

	2.	Extension of Research Program. The Research Program will be extended through December 31, 2015. During 2015, Amgen will support [***] Cytokinetics FTE at the 2015 FTE Rate of [***]. The current Research Plan
is attached as Exhibit A. 

  

	3.	Additional Milestones. The following is hereby added as Section 13.3.10: 

 Amgen
shall pay CK the amounts set forth in Table 13.3.10 below on [***] occurrence of the following events with respect to [***] that achieves any such milestone within the Collaboration: 

 

					
	Table 13.3.10	 
	 Milestone Event
	  	Amount Payable	 
	 [***]
	  	 	[	***] 
	 [***]
	  	 	[	***] 

  

	*	For purposes of clarity, [***]. 

 [***] = Certain confidential information contained in this document, marked
by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. 

Amgen contract no. 200625165-040 

			
	Confidential		EXECUTION COPY

  

 (a) [***] Development Plan or Development Program [***] by the JRC for evaluation by the JDC
pursuant to Section [***]. 
 (b) [***] Amgen under Sections [***], regardless of the [***]. 

(c) [***] milestone in Table 13.3.10 [***] Compound. 

Except as expressly set forth herein, all of the terms and conditions of the Agreement will remain in full force and effect. This Amendment No. 7
constitutes the entire agreement between the Parties as to its subject matter, and supersedes and merges all prior negotiations, representations, agreements and understandings regarding the same. 

IN WITNESS WHEREOF, the Parties have executed this Amendment No. 7 as of the Amendment Effective Date. 

 

									
	Cytokinetics, Inc.				Amgen Inc.
					
	By:  		 /s/ Robert I. Blum
				By:  		 /s/ Sean E. Harper

	Name: Robert I. Blum				Name: Sean E. Harper
	Title: President and CEO				Title: EVP Research & Development

  
 [***] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. 

 

					
	Amgen contract no. 200625165-040		Page 2 of 3		

			
	Confidential		EXECUTION COPY

  

 EXHIBIT A 

Research Plan 
 [***] 

  
 [***] = Certain confidential
information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. 

 

					
	Amgen contract no. 200625165-040		Page 3 of 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}]]